Cite
HARVARD Citation
Wright, A. et al. (n.d.). Vedolizumab is safe and effective in moderate‐to‐severe inflammatory bowel disease following liver transplantation. Liver transplantation. 23 (7), pp. 968-971. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wright, A. et al. (n.d.). Vedolizumab is safe and effective in moderate‐to‐severe inflammatory bowel disease following liver transplantation. Liver transplantation. 23 (7), pp. 968-971. [Online].